Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05841784 · ClinicalTrials.gov registry record · NA
HARP Mindfulness Study
A NA study, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT05841784 is a NA study that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 160 participants.
The verdict
NCT05841784, a NA study, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study was designed using the Multiphase Optimization Strategy (MOST) framework to determine whether two supplemental components increase the efficacy of a mindfulness-based cognitive therapy program delivered via telephone (MBCT-T) for psychological distress. Specifically, this study will test mindfulness booster sessions to follow a standard 8-week MBCT-T intervention, as well as website support in patients with heart disease and/or heart disease risk factors.
Interventions
- BEHAVIORAL MBCT-T
- BEHAVIORAL Booster Mindfulness Sessions
- BEHAVIORAL Website Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-05-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05841784
The ClinicalTrials.gov registry entry for NCT05841784 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MBCT-T is the first listed.
NCT05841784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05841784 about?
NCT05841784 is a clinical study titled "HARP Mindfulness Study". This study was designed using the Multiphase Optimization Strategy (MOST) framework to determine whether two supplemental components increase the efficacy of a mindfulness-based cognitive therapy program delivered via telephone (MBCT-T) for psychological distress. Specifically, this study will test ...
What is the current status of trial NCT05841784?
This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-05-15. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT05841784?
The interventions under investigation include: MBCT-T (BEHAVIORAL), Booster Mindfulness Sessions (BEHAVIORAL), Website Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05841784?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.